MEMPHASYS LIMITED.
ASX:MEMPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 79.7% of what they think they own, once every option and right converts.
Share count grew 114% in 24 months; runway 2–4 quarters; 8 cash raises in 24 months
MEMPHASYS LIMITED's ordinary share count grew 114.2% between August 2024 and September 2026, its latest share-count filing, to 3.10B shares. The company raised capital eight times in the past 24 months for total disclosed proceeds of A$10.1M, most recently a A$3.5M Convertible Note Placement in September 2026. Options and rights on issue could convert into 788M new shares, representing a potential overhang of 25.5%, none of which are in the money at the current share price; the nearest expiry is November 2026. The company has 2 to 4 quarters of funding at the recent spend rate. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in December 2026.
Quick answers · 4
Is MEM raising capital?
Memphasys has 1 proposed issue of securities pending under Appendix 3B as at 28 Oct 2026; the most recent raise announced is Convertible Note Placement of $3.5M on 29 Sept 2026.
How much cash does MEM have?
In its quarterly cash report for the quarter ended 30 Sept 2026, Memphasys reported $3.5M of cash and estimated 3.0 quarters of funding available at its current rate of spending. That is the company's own estimate.
When do MEM's options expire?
Unexercised options and rights equal 25.5% of Memphasys's shares on issue; the nearest expiry is Nov 2026.
How much has MEM's share count grown?
Memphasys has 3.10B shares on issue as at 28 Oct 2026, up 114.2% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 14 Oct 2026 | 3G · unquoted | MEM : ORDINARY FULLY PAID | 3.10B | Appendix 3G |
| 18 Sept 2026 | 2A · quoted issue | MEM : ORDINARY FULLY PAID | 3.10B | Appendix 2A |
| 18 Sept 2026 | 3G · unquoted | ORDINARY FULLY PAID | 3.09B | Appendix 3G |
| 18 Sept 2026 | 3G · unquoted | ORDINARY FULLY PAID | 3.09B | Appendix 3G |
| 2 Sept 2026 | 3H · cancellation | MEM : ORDINARY FULLY PAID | 3.09B | Appendix 3H |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
7 cash raises in the last 24 months · 3 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
- Price-triggered784.0M · 25.3% of sharesOptions and warrants — they convert when the share price clears their exercise price.
- Condition-triggered4.5M · 0.1% of sharesPerformance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
Exercise price on record: 784.0M priced (of which 13.0M in the money), 4.5M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.
Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.
At $0.004 today, 13.0M securities are in the money (0.4% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 30.0M (1.0% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 4.5M (0.6% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| MEMAX | Options | Price-triggered | $0.011 | 5 Nov 2026 | 479.8M | Filing |
| MEMAY | Options | Price-triggered | $0.011 | 8 Nov 2026 | 8.3M | Filing |
| MEMAZ | Options | Price-triggered | $0.011 | 20 Dec 2026 | 7.9M | Filing |
| MEMAG | Options | Price-triggered | $0.006 | 15 Jan 2027 | 7.0M | Filing |
| MEMAV | Options | Price-triggered | $0.015 | 15 Feb 2027 | 13.4M | Filing |
| MEMAC | Options | Price-triggered | $0.011 | 16 Apr 2027 | 212.6M | Filing |
| MEMAD | Options | Price-triggered | $0.004 | 19 Dec 2027 | 6.5M | Filing |
| MEMAE | Options | Price-triggered | $0.005 | 19 Dec 2027 | 8.5M | Filing |
| MEMAF | Options | Price-triggered | $0.007 | 19 Dec 2027 | 10.0M | Filing |
| MEMAAC | Options | Price-triggered | $0.004 | 31 Dec 2027 | 6.5M | Filing |
| MEMAAD | Options | Price-triggered | $0.005 | 31 Dec 2027 | 8.5M | Filing |
| MEMAAE | Options | Price-triggered | $0.007 | 31 Dec 2027 | 15.0M | Filing |
| — | Performance rights | Condition-triggered | — | — | 4.5M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
- MEMAOconvertible notes3.0M14 Oct 2026 Appendix 2A
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 18 Sept 2026 | David Raymond Tasker | Other | 8.0M | 2.5M | — | $40k | 3Y notice |
| 19 Dec 2025 | Dr Lindley Edwards | Other | 5.8M | — | — | — | 3Y notice |
| 19 Dec 2025 | Marjan Mikel | Other placement | 6.7M | 27.0M | — | $20k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.